Viruses (Apr 2024)

Natural Killer Cells Do Not Attenuate a Mouse-Adapted SARS-CoV-2-Induced Disease in <i>Rag2</i><sup>−/−</sup> Mice

  • Calder R Ellsworth,
  • Chenxiao Wang,
  • Alexis R Katz,
  • Zheng Chen,
  • Mohammad Islamuddin,
  • Haoran Yang,
  • Sarah E Scheuermann,
  • Kelly A Goff,
  • Nicholas J Maness,
  • Robert V Blair,
  • Jay K Kolls,
  • Xuebin Qin

DOI
https://doi.org/10.3390/v16040611
Journal volume & issue
Vol. 16, no. 4
p. 611

Abstract

Read online

This study investigates the roles of T, B, and Natural Killer (NK) cells in the pathogenesis of severe COVID-19, utilizing mouse-adapted SARS-CoV-2-MA30 (MA30). To evaluate this MA30 mouse model, we characterized MA30-infected C57BL/6 mice (B6) and compared them with SARS-CoV-2-WA1 (an original SARS-CoV-2 strain) infected K18-human ACE2 (K18-hACE2) mice. We found that the infected B6 mice developed severe peribronchial inflammation and rapid severe pulmonary edema, but less lung interstitial inflammation than the infected K18-hACE2 mice. These pathological findings recapitulate some pathological changes seen in severe COVID-19 patients. Using this MA30-infected mouse model, we further demonstrate that T and/or B cells are essential in mounting an effective immune response against SARS-CoV-2. This was evident as Rag2−/− showed heightened vulnerability to infection and inhibited viral clearance. Conversely, the depletion of NK cells did not significantly alter the disease course in Rag2−/− mice, underscoring the minimal role of NK cells in the acute phase of MA30-induced disease. Together, our results indicate that T and/or B cells, but not NK cells, mitigate MA30-induced disease in mice and the infected mouse model can be used for dissecting the pathogenesis and immunology of severe COVID-19.

Keywords